Malignant melanoma--identification of high risk groups
Kardinal, C.G.; Carolla, R.L.
Missouri Medicine 73(12): 666-668; 672
1976
ISSN/ISBN: 0026-6620 PMID: 1004477 Document Number: 101857
Document emailed within 1 workday
Related Documents
Ishihara, K. 1987: Skin malignant tumor. High-risk groups Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(9): 2667-2671Donckier, V.; Vereecken, P.; Blocklet, D.; Laporte, M.; Velu, T.; Heenen, M.; Van Geertruyden, J. 1999: Sentinel lymph node mapping in the management of high risk malignant melanoma Acta Chirurgica Belgica 99(6): 295-298
Monti, M.; Berti, E.; Cavicchini, S.; Paindelli, M.G.; Terragni, L. 1985: Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 120(4): 297-306
Pavlov, K.A.; Berezkin, D.P.; Shabashova, N.I.; Mirotvortseva, K.S. 1973: Criteria for determining high risk groups in the population with regard to the incidence of malignant tumors in the chief locations Voprosy Onkologii 19(10): 105-110
Wong, W.-W.; Huang, C.-T.; Li, L.-H.; Chiang, C.-C.; Chen, B.-D.; Li, S.-Y. 2008: Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis Journal of Clinical Microbiology 46(12): 3931-3934
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Jonasch, E.; Kumar, U.N.; Linette, G.P.; Hodi, F.S.; Soiffer, R.J.; Ryan, B.F.; Sober, A.J.; Mihm, M.C.; Tsao, H.; Langley, R.G.; Cosimi, B.A.; Gadd, M.A.; Tanabe, K.K.; Souba, W.; Haynes, H.A.; Barnhill, R.; Osteen, R.; Haluska, F.G. 2000: Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma Cancer Journal 6(3): 139-145
Mosbech, J. 1972: Identification of risk groups in a population Ugeskrift for Laeger 134(30): 1577-1578
Karakousis, C.P.; Carlson, M. 1979: High-dose methotrexate in malignant melanoma Cancer Treatment Reports 63(8): 1405-1407
Sibthorpe, B.; Fleming, D.; Gould, J. 1994: Self-help groups: a key to HIV risk reduction for high-risk injection drug users? Journal of Acquired Immune Deficiency Syndromes 7(6): 592-598
Ninet, J. 2003: The risk of maternal venous thromboembolism disease. Synopsis and definition of high-risk groups Annales de Medecine Interne 154(5-6): 301-309
Islam, M.Mofizul.; Conigrave, K.M. 2008: HIV and sexual risk behaviors among recognized high-risk groups in Bangladesh: need for a comprehensive prevention program International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 12(4): 363-370
Islam, M.Mofizul.; Conigrave, K.M. 2008: HIV and sexual risk behaviors among recognized high-risk groups in Bangladesh: need for a comprehensive prevention program International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 12(4): 363-370
Gomes do Espirito Santo, M.E.; Etheredge, G.D. 2005: Male clients of brothel prostitutes as a bridge for HIV infection between high risk and low risk groups of women in Senegal Sexually Transmitted Infections 81(4): 342-344
Mustikawati, D.E.; Morineau, G.; Nurhayati; Irmaningrum, Y.; Riono, P.; Priohutomo, S.; Magnani, R. 2009: Sexual risk taking, sexually transmitted infections and HIV prevalence among four "high-risk" occupational groups of Indonesian men Sexually Transmitted Infections 85(5): 391-396
Sekar, R.; Amudhan, M.; Sivashankar, M.; Veeran, R.; Jayachandran, C.; Mythreyee, M. 2011: Declining trend of HIV infection among the rural population of South India - a comparison of HIV prevalence in high risk and low risk groups Journal of Infection 63(1): 91-92
Caha, A.; Ott, O.; Krystof, V. 1978: Surface therapy of malignant melanoma by high-energy electrons Ceskoslovenska Radiologie 32(5): 333-336
Shannan, B.; Seifert, M.; Leskov, K.; Boothman, D.; Pföhler, C.; Tilgen, W.; Reichrath, J. 2006: Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro Anticancer Research 26(4a): 2707-2716
Zwerling, C.; Ryan, J.; Schootman, M. 1993: A case-control study of risk factors for industrial low back injury. The utility of preplacement screening in defining high-risk groups Spine 18(9): 1242-1247
Coutris, G.; Talbot, J.N.; Kiffel, T.; Paus, L.; Milhaud, G. 1985: Risk of vertebral fracture after menopause: identification of subjects at high risk by dual photon absoprtionometry Biomedicine and PharmacoTherapy 39(1): 35-39